SPINI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 410
NA - Nord America 252
AS - Asia 50
AF - Africa 11
OC - Oceania 1
Totale 724
Nazione #
US - Stati Uniti d'America 252
IE - Irlanda 106
GB - Regno Unito 93
IT - Italia 54
RU - Federazione Russa 46
SE - Svezia 37
DE - Germania 23
SG - Singapore 20
FR - Francia 19
FI - Finlandia 16
VN - Vietnam 12
CI - Costa d'Avorio 10
IN - India 8
CN - Cina 7
ES - Italia 5
UA - Ucraina 5
BE - Belgio 2
NL - Olanda 2
TR - Turchia 2
AU - Australia 1
GR - Grecia 1
IL - Israele 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 724
Città #
Dublin 106
Southend 89
Ashburn 38
Chandler 32
Fairfield 21
Siena 17
Singapore 16
Munich 14
Ann Arbor 12
Princeton 12
Woodbridge 12
Dong Ket 11
Helsinki 11
Seattle 11
Wilmington 11
Abidjan 10
Florence 8
Moscow 8
Pune 7
San Diego 7
Houston 6
Málaga 5
Cambridge 4
Columbus 4
Espoo 4
Fremont 4
San Mateo 4
Beijing 3
Dearborn 3
Rome 3
Amsterdam 2
Brussels 2
Jacksonville 2
London 2
Monte 2
New York 2
Prato 2
Washington 2
Abbadia San Salvatore 1
Athens 1
Bassano del Grappa 1
Boardman 1
Bratislava 1
Brescia 1
Busto Arsizio 1
Canberra 1
Centurion 1
Chiswick 1
Dallas 1
Frankfurt am Main 1
Gunzenhausen 1
Kocaeli 1
Kolkata 1
Lappeenranta 1
Los Angeles 1
Milan 1
Monteroni d'Arbia 1
Or Yehuda 1
Phoenix 1
Poggio Renatico 1
Quanzhou 1
Redmond 1
San Francisco 1
Sansepolcro 1
Santa Clara 1
Shanghai 1
Taizhou 1
The Dalles 1
Totale 539
Nome #
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 149
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 110
Repurposing of drugs for triple negative breast cancer: an overview 96
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 79
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 79
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 74
Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? 53
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis 40
Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry 38
Sex differences in the utilization of drugs for COVID-19 treatment among elderly residents in a sample of Italian nursing homes 33
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications 16
Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study 12
Totale 779
Categoria #
all - tutte 4.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 12 7 6 7 5 6 3 2
2020/2021121 10 2 4 5 6 18 4 21 15 9 4 23
2021/2022125 3 11 11 12 8 9 5 6 3 11 22 24
2022/2023178 8 10 20 11 26 50 13 13 13 6 7 1
2023/2024183 6 8 17 11 6 54 59 3 1 3 0 15
2024/2025119 12 22 33 39 13 0 0 0 0 0 0 0
Totale 779